Targeted suppression of calpain-10 expression impairs insulin-stimulated glucose uptake in cultured primary human skeletal muscle cells

Molecular Genetics and Metabolism

Volumn 91, Issue 4, 2007, Pages 318-324

  Brown, Audrey E ^a   Yeaman, Stephen J ^b   Walker, Mark ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Calpain 10; Diabetes mellitus; Insulin action

Indexed keywords

CALPAIN 10; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; MESSENGER RNA; PROTEIN KINASE B; SMALL INTERFERING RNA;

ARTICLE; CAPN10 GENE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WESTERN BLOTTING;

BIOLOGICAL TRANSPORT; CALPAIN; CELLS, CULTURED; DEOXYGLUCOSE; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; HUMANS; INSULIN; MUSCLE, SKELETAL; POLYMERASE CHAIN REACTION; RNA; RNA, SMALL INTERFERING;

EID: 34447248794     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.05.001     Document Type: Article

References (30)

1. Shulman G.I., Rothman D.L., Jue T., Stein P., DeFronzo R.A., and Shulman R.G. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322 (1990) 223-228
2. Hanis C.L., Boerwinkle E., Chakraborty R., Ellsworth D.L., Concannon P., Stirling B., Morrison V.A., Wapelhorst B., Spielman R.S., Gogolin-Ewens K.J., Shepard J.M., Williams S.R., Risch N., Hinds D., Iwasaki N., Ogata M., Omori Y., Petzold C., Rietzch H., Schroder H.E., Schulze J., Cox N.J., Menzel S., Boriraj V.V., Chen X., Lim L.R., Lindner T., Mereu L.E., Wang Y.Q., Xiang K., Yamagata K., Yang Y., and Bell G.I. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat. Genet. 13 (1996) 161-166
3. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., Hinokio Y., Lindner T.H., Mashima H., Schwarz P.E., del Bosque-Plata L., Oda Y., Yoshiuchi I., Colilla S., Polonsky K.S., Wei S., Concannon P., Iwasaki N., Schulze J., Baier L.J., Bogardus C., Groop L., Boerwinkle E., Hanis C.L., and Bell G.I. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26 (2000) 163-175
4. Baier L.J., Permana P.A., Yang X., Pratley R.E., Hanson R.L., Shen G.Q., Mott D., Knowler W.C., Cox N.J., Horikawa Y., Oda N., Bell G.I., and Bogardus C. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J. Clin. Invest. 106 (2000) R69-R73
5. Carlsson E., Poulsen P., Storgaard H., Almgren P., Ling C., Bjorn Jensen C., Madsbad S., Groop L., Vaag A., and Ridderstrale M. Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle. Diabetes 54 (2005) 3015-3020
6. Lynn S., Evans J.C., White C., Frayling T.M., Hattersley A.T., Turnbull D.M., Horikawa Y., Cox N.J., Bell G.I., and Walker M. Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 51 (2002) 247-250
7. Orho-Melander M., Klannemark M., Svensson M.K., Ridderstrale M., Lindgren C.M., and Groop L. Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51 (2002) 2658-2664
8. Stumvoll M., Fritsche A., Madaus A., Stefan N., Weisser M., Machicao F., and Haring H. Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes 50 (2001) 2161-2163
9. Cassell P.G., Jackson A.E., North B.V., Evans J.C., Syndercombe-Court D., Phillips C., Ramachandran A., Snehalatha C., Gelding S.V., Vijayaravaghan S., Curtis D., and Hitman G.A. Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 51 (2002) 1622-1628
10. Weedon M.N., Schwarz P.E., Horikawa Y., Iwasaki N., Illig T., Holle R., Rathmann W., Selisko T., Schulze J., Owen K.R., Evans J., Del Bosque-Plata L., Hitman G., Walker M., Levy J.C., Sampson M., Bell G.I., McCarthy M.I., Hattersley A.T., and Frayling T.M. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am. J. Hum. Genet. 73 (2003) 1208-1212
11. Malecki M.T., Moczulski D.K., Klupa T., Wanic K., Cyganek K., Frey J., and Sieradzki J. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur. J. Endocrinol. 146 (2002) 695-699
12. Evans J.C., Frayling T.M., Cassell P.G., Saker P.J., Hitman G.A., Walker M., Levy J.C., O'Rahilly S., Rao P.V., Bennett A.J., Jones E.C., Menzel S., Prestwich P., Simecek N., Wishart M., Dhillon R., Fletcher C., Millward A., Demaine A., Wilkin T., Horikawa Y., Cox N.J., Bell G.I., Ellard S., McCarthy M.I., and Hattersley A.T. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am. J. Hum. Genet. 69 (2001) 544-552
13. Jensen D.P., Urhammer S.A., Eiberg H., Borch-Johnsen K., Hamsen T., and Pedersen O. Variation in CAPN10 in relation to type 2 diabetes, obesity and quantitative metabolic traits: studies in 6018 whites. Mol. Genet. Metab. 89 (2006) 360-367
14. Rasmussen S.K., Urhammer S.A., Berglund L., Jensen J.N., Hansen L., Echwald S.M., Borch-Johnsen K., Horikawa Y., Mashima H., Lithell H., Cox N.J., Hansen T., Bell G.I., and Pedersen O. Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 51 (2002) 3561-3567
15. Horikawa Y., Oda N., Yu L., Imamura S., Fujiwara K., Makino M., Seino Y., Itoh M., and Takeda J. Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. J. Clin. Endocrinol. Metab. 88 (2003) 244-247
16. Fingerlin T.E., Erdos M.R., Watanabe R.M., Wiles K.R., Stringham H.M., Mohlke K.L., Silander K., Valle T.T., Buchanan T.A., Tuomilehto J., Bergman R.N., Boehnke M., and Collins F.S. Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 51 (2002) 1644-1648
17. Tsai H.J., Sun G., Weeks D.E., Kaushal R., Wolujewicz M., McGarvey S.T., Tufa J., Viali S., and Deka R. Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am. J. Hum. Genet. 69 (2001) 1236-1244
18. Ma H., Fukiage C., Kim Y.H., Duncan M.K., Reed N.A., Shih M., Azuma M., and Shearer T.R. Characterization and expression of calpain 10 A novel ubiquitous calpain with nuclear localization. J. Biol. Chem. 276 (2001) 28525-28531
19. Yang X., Pratley R.E., Baier L.J., Horikawa Y., Bell G.I., Bogardus C., and Permana P.A. Reduced skeletal muscle calpain-10 transcript level is due to a cumulative decrease in major isoforms. Mol. Genet. Metab. 73 (2001) 111-113
20. Sreenan S.K., Zhou Y.P., Otani K., Hansen P.A., Currie K.P., Pan C.Y., Lee J.P., Ostrega D.M., Pugh W., Horikawa Y., Cox N.J., Hanis C.L., Burant C.F., Fox A.P., Bell G.I., and Polonsky K.S. Calpains play a role in insulin secretion and action. Diabetes 50 (2001) 2013-2020
21. Logie L.J., Brown A.E., Yeaman S.J., and Walker M. Calpain inhibition and insulin action in cultured human muscle cells. Mol. Genet. Metab. 85 (2005) 54-60
22. Paul D.S., Harmon A.W., Winston C.P., and Patel Y.M. Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem. J. 376 (2003) 625-632
23. Blau H.M., and Webster C. Isolation and characterization of human muscle cells. Proc. Natl. Acad. Sci. USA 78 (1981) 5623-5627
24. Al-Khalili L., Cartee G.D., and Krook A. RNA interference-mediated reduction in GLUT1 inhibits serum-induced glucose transport in primary human skeletal muscle cells. Biochem. Biophys. Res. Commun. 307 (2003) 127-132
25. Eyster C.A., Duggins Q.S., and Olson A.L. Expression of constitutively active Akt/protein kinase B signals GLUT4 translocation in the absence of an intact actin cytoskeleton. J. Biol. Chem. 280 (2005) 17978-17985
26. Wang Q., Somwar R., Bilan P.J., Liu Z., Jin J., Woodgett J.R., and Klip A. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell Biol. 19 (1999) 4008-4018
27. Ueki K., Yamamoto-Honda R., Kaburagi Y., Yamauchi T., Tobe K., Burgering B.M., Coffer P.J., Komuro I., Akanuma Y., Yazaki Y., and Kadowaki T. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J. Biol. Chem. 273 (1998) 5315-5322
28. Shepherd P.R., and Kahn B.B. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341 (1999) 248-257
29. Zhou Y.P., Sreenan S., Pan C.Y., Currie K.P., Bindokas V.P., Horikawa Y., Lee J.P., Ostrega D., Ahmed N., Baldwin A.C., Cox N.J., Fox A.P., Miller R.J., Bell G.I., and Polonsky K.S. A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism 52 (2003) 528-534
30. Marshall C., Hitman G.A., Partridge C.J., Clark A., Ma H., Shearer T.R., and Turner M.D. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Mol. Endocrinol. 19 (2005) 213-224